Refine your search
-
Authors
-
Item types
-
Topics
- *Antibodies, Monoclonal, Humanized/tu [Therapeutic Use]
- *Antineoplastic Agents/tu [Therapeutic Use]
- *Imidazoles/tu [Therapeutic Use]
- *Immunotherapy/mt [Methods] [x]
- *Melanoma/dt [Drug Therapy] [x]
- *Melanoma/th [Therapy]
- *Oximes/tu [Therapeutic Use]
- *Pyridones/tu [Therapeutic Use]
- *Pyrimidinones/tu [Therapeutic Use]
- Antibodies, Monoclonal, Humanized/im [Immunology]
- Antineoplastic Agents/im [Immunology]
- Combined Modality Therapy
- Cyclin-Dependent Kinase 4/ai [Antagonists & Inhibitors]
- Cyclin-Dependent Kinase 4/im [Immunology]
- Cyclin-Dependent Kinase 6/ai [Antagonists & Inhibitors]
- Cyclin-Dependent Kinase 6/im [Immunology]
- Endpoint Determination
- Humans
- Imidazoles/im [Immunology]
- Melanoma/im [Immunology]
- Show more
- Show less
-
Collections
-
Languages